BioTech
The DRC ‘mystery illness’ shows why the U.S. can’t ‘pause’ infectious disease work
Our phones buzz with the same question every time an unusual outbreak makes the news: “What’s happening?” As physicians and frequent responders to infectious threats
Craig Spencer and Nahid Bhadelia
December 19, 2024